The global microcrystalline cellulose market is gaining momentum as pharmaceutical, food and beverage, personal care, and other formulation-intensive industries increasingly seek reliable, functional, and versatile cellulose-based ingredients. Microcrystalline cellulose (MCC) is valued for its excellent binding, compressibility, disintegration, stabilization, and texture-enhancing properties. Its established regulatory acceptance and compatibility with a wide range of formulations have made it an important excipient and specialty ingredient across multiple industries.

Market Size and Key Growth Indicators

The market is benefiting from increasing pharmaceutical production, rising demand for processed and packaged foods, and growing interest in plant-derived and sustainable ingredients. Pharmaceutical manufacturers particularly rely on MCC for solid dosage formulations because of its ability to support consistent tablet quality and efficient large-scale manufacturing.

Key market figures from Grand View Research include:

• Market size, 2025: USD 1.2 billion

• Estimated market size, 2026: USD 1.3 billion

• Projected market size, 2033: USD 2.3 billion

• CAGR, 2026–2033: 7.8%

• Asia Pacific revenue share, 2025: 37.8%

The market's expansion is also supported by the increasing use of functional ingredients in food and personal care formulations. In food and beverages, MCC can contribute to texture, stability, and calorie-reduction formulations, while personal care manufacturers use it for formulation stability and sensory properties. 

Download a free sample copy of the Microcrystalline Cellulose Market report to understand detailed coverage and inclusions in the final report

Pharmaceuticals Remain a Major Application Area

Pharmaceutical manufacturing represents one of the strongest demand centers for microcrystalline cellulose. MCC is widely used as a pharmaceutical excipient because of its binding, disintegration, flow, and compressibility characteristics. These properties make it particularly suitable for tablets and other solid dosage forms.

The growing production of generic medicines and expansion of pharmaceutical manufacturing capacity are creating additional opportunities for MCC suppliers. Manufacturers increasingly require excipients that can deliver consistent performance while meeting strict quality and regulatory requirements.

According to Grand View Research, the pharmaceutical segment accounted for 33.9% of total market revenue in 2025, making it the leading end-use segment. Meanwhile, the personal care segment is projected to grow at the fastest rate, with a CAGR of 8.2% from 2026 to 2033. 

Wood-Based MCC Continues to Lead

Microcrystalline cellulose is produced from cellulose obtained from natural sources, with wood pulp remaining an important raw material. Wood-based MCC benefits from established production infrastructure, consistent cellulose quality, predictable processing characteristics, and broad acceptance in pharmaceutical and food applications.

Source segment highlights:

• Wood-based revenue share, 2025: 63.9%

• Non-wood-based CAGR, 2026–2033: 8.4%

The non-wood-based segment is expected to gain momentum as manufacturers explore alternative cellulose sources, including agricultural residues and plant fibers. Improvements in purification and processing technologies can expand the suitability of these sources for nutraceutical, food, and specialty applications. 

Powdered Form Dominates Market Demand

Formulation requirements vary significantly across industries, but powdered microcrystalline cellulose remains the most widely adopted form. Its ease of handling, long shelf life, compressibility, and compatibility with dry blending processes make it particularly valuable in pharmaceutical and nutraceutical manufacturing.

• Powdered form revenue share, 2025: 60.3%

• Liquid form CAGR, 2026–2033: 8.3%

Although powdered MCC currently leads the market, liquid MCC is expected to record faster growth. Its dispersion-friendly characteristics make it useful for applications involving beverages, coatings, and personal care products. Increasing demand for ready-to-use formulations may further support adoption of liquid forms. 

Asia Pacific Holds a Strong Market Position

Asia Pacific represents a major center for microcrystalline cellulose consumption and production. Strong pharmaceutical manufacturing activity, expanding food processing industries, increasing healthcare expenditure, and a large consumer base are supporting demand throughout the region.

The region accounted for 37.8% of global market revenue in 2025, making it the leading regional market. China is particularly important, accounting for over 43.9% of Asia Pacific's revenue share in 2025. 

China's expanding pharmaceutical manufacturing base and increasing focus on domestic excipient production are contributing to market development. Meanwhile, investments in food processing and healthcare products are creating additional opportunities for MCC suppliers.

Europe is also expected to register strong growth, with Grand View Research projecting a 7.8% CAGR from 2026 to 2033. Strict quality standards, pharmaceutical innovation, sustainable sourcing initiatives, and demand for high-performance excipients are supporting the European market. 

Looking for more specific insights? Customize this report to suite your business needs

Competitive Landscape and Industry Development

The microcrystalline cellulose industry features established international manufacturers as well as regional producers. Competition is shaped by product quality, regulatory compliance, technical expertise, manufacturing consistency, and supply reliability. Buyers in pharmaceutical and food applications typically place significant emphasis on traceability and dependable product performance.

Grand View Research identifies companies including:

• JRS Pharma

• FMC BioPolymer

• DFE Pharma GmbH & Co. KG

• Asahi Kasei Corporation

• Roquette Frères

• International Flavors & Fragrances Inc. (IFF)

• Mingtai Chemical Co., Ltd.

• Sigachi Industries Pvt. Ltd.

• Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

• Accent Microcell Pvt. Ltd.

The industry is also seeing strategic developments aimed at strengthening supply chains and excipient capabilities. In March 2025, Oji Holdings Corporation acquired a stake in India-based Chemfield Cellulose, supporting greater integration across the MCC value chain. 

Future Outlook

The outlook for the microcrystalline cellulose market remains positive as pharmaceutical production, functional food applications, personal care formulations, and demand for plant-derived ingredients continue to evolve. Manufacturers are increasingly focused on sustainable sourcing, formulation efficiency, and consistent product performance.

With the market projected to reach USD 2.3 billion by 2033 and expand at a 7.8% CAGR from 2026 to 2033, microcrystalline cellulose is positioned for sustained growth across established and emerging applications. The combination of pharmaceutical demand, expanding personal care usage, alternative cellulose sourcing, and regional manufacturing expansion is expected to remain central to the industry's development over the coming years.